Table 1.
Ambulatory care visits’ characteristics for patients diagnosed with Schizophrenia-Spectrum Disorders (SSDs): Data from the NAMCS 2010–2015 (N = 1155)
| Variable | Number of visits | Weighted % |
|---|---|---|
| Age | ||
|
• 18–44 • 45–64 • 65+ |
477 520 158 |
37.4 48.5 14.1 |
| Gender | ||
|
• Female • Male |
493 662 |
43.7 56.3 |
| Race/ethnicity | ||
|
• White • Black • Hispanic • Asian/Other identies |
700 253 129 73 |
61.8 21.2 11.4 5.6 |
| Insurance | ||
|
• Private • Medicare • Medicaid • Other |
162 465 334 194 |
15.0 39.1 27.0 18.9 |
| Psychotic Disorders (% Yes) | ||
|
• Schizophrenia Dx • Schizoaffective Dx • Unspecified psychosis Dx |
526 415 230 |
44.8 37.4 19.0 |
| Co-morbidity (% Yes) | ||
|
• Lung Dx (Asthma, COPD) • CVD (CVD, Hyperlipidemia) • Depression • Diabetes • Hypertension • Other Co-morbidities* |
79 151 300 124 236 180 |
7.9 13.6 25.6 11.3 23.5 15.2 |
| Disposition (% Yes) | ||
|
• Refer to another physician • Return at specified time/Follow up • Another visit disposition (include ER and Hosp) |
59 1024 117 |
6.3 90.1 8.6 |
| Medication Use (% Yes) | ||
|
• Psychotropic Rx (monotherapy or combination) • Antidepressants • Antipsychotics |
944 456 886 |
82.1 39.4 75.8 |
*Other comorbidities include: Arthritis, Cancer, Chronic renal failure, Congestive heart failure, Obesity, Osteoporosis